About Us
Pharmaceutical Executive® provides insights and stories behind successful commercial strategies, research and development (R&D), market access and more, to its audience of pharmaceutical executives. Our original print and digital content is produced by a team of fulltime, in-house writers and industry experts, which makes us stand out from the competition.
We go beyond the 24-hour news cycle and provide in-depth analysis and the strategic context to help executives navigate the maze of policy and business challenges that face this changing industry.
Advertisement
Advertisement
Trending on PharmExec
1
Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion
2
Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche
3
Is Participation in MFN Voluntary?
4
The Bubble You Don’t Know You’re In: A Three-Part Series on The Medical Benefit Bubble
5
